Workshop Series

Overcoming Challenges in the Treatment of Relapsed/Refractory Multiple Myeloma

Released:

5/1/13

Expires:

7/12/14

Maximum Credits:

2.5

Activity is closed

Workshop Series

Activity is closed

Released:

5/1/13

Expires:

7/12/14

Maximum Credits:
2.5

Workshop Series

Activity is closed

Released:

5/1/13

Expires:

7/12/14

Maximum Credits:
2.5

Overview: This interactive workshop provides hematology/oncology clinicians with strategies to guide therapeutic decision making for patients with relapsed/refractory multiple myeloma. It features small-group case discussions to illustrate practical solutions for addressing issues associated with managing this stage of disease.

Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.

Disclosure Statement

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.